startup baselland supports company creation
BaselArea.swiss is working with selected organizations and Standortförderung Baselland to support the foundation of companies in the canton of Basel-Landschaft. At the root of the partnerships is the initiative startup baselland.
About 100 people were interested in the kickoff of startup baselland in Muttenz (Photo: Dümpelmann)
The success of a startup relies on certain decisive measures when preparing to launch. With this is mind, the new initiative startup baselland is acting to support successful company creation, announced a statement. Three founder hubs – Business Parc Reinach, Business Park Oberbaselbiet/Laufental & Thierstein and Startup Academy Liestal – are working with BaselArea.swiss and the location promotion organization Standortförderung Baselland, which is leading the initiative.
The initiative launched with an event organized by Business Parc Reinach at Campus Muttenz of the University of Applied Sciences and Arts Northwestern Switzerland. Experts spoke about opportunities and risks associated with self-employment, presented approaches and tactics, and showcased the services offered by the participating organizations. The event was rounded off by owners of startups in the region speaking about their experiences.
With projects like this, the initiative intends to reach its “higher goal” of increasing the number of sustainable company creations. This would boost economic power and innovation and create jobs in the canton of Basel-Landschaft.
“We plan to use targeted activities to bring fresh impetus, entrepreneurial force and an attractive location for startups to the region. It is also important to increase awareness of entrepreneurialism in society,” commented Thomas Kübler, Head of Standortförderung Baselland. The kickoff event will be followed by roadshows across the Basel area in the coming year.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More